Intech Investment Management LLC Catalent, Inc. Transaction History

Intech Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 18, 2024	BUY	$45.44 - $74.26 $11.4 Million - $18.6 Million	250,427 New	250,427 $16.5 Million
Q1 2023 May 10, 2023	BUY	$45.44 - $74.26 $5.24 Million - $8.56 Million	115,297 Added 85.32%	250,427 $16.5 Million
Q4 2022 Oct 18, 2024	BUY	$41.39 - $81.0 $4.97 Million - $9.73 Million	120,141 Added 801.53%	135,130 $6.08 Million
Q4 2022 Feb 09, 2023	BUY	$41.39 - $81.0 $4.97 Million - $9.73 Million	120,141 Added 801.53%	135,130 $6.08 Million
Q3 2022 Oct 18, 2024	BUY	$72.36 - $113.1 $1.08 Million - $1.7 Million	14,989 New	14,989 $1.08 Million
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $3.47 Million - $5.42 Million	-47,902 Reduced 76.17%	14,989 $1.08 Million
Q2 2022 Aug 10, 2022	BUY	$87.2 - $114.05 $5.48 Million - $7.17 Million	62,891 New	62,891 $6.75 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intech Investment Management LLC with notifications on news.